Get Started
HBV Curricula
Step 1




The Advanced Certificate Program in Chronic Hepatitis B Management V
Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
  1. Curriculum VII
  2. Curriculum VI
  3. Curriculum V
  4. Curriculum IV
  5. Full Course List
Search by


Currently Available

Course Title Curriculum Faculty Release Date
Expert Insight Into: A Nucleotide Analog Is Effective Alone or with a Nucleoside Analog in Chronic Hepatitis B Patients Previously Treated with Another Nucleotide Analog (Part 12 of Series)Article Review (HBV5.17) 1969.12 V Kim Dec 2010
Case Study: Focus on Long-Term TherapyTx Reporter e-Newsletter (HBV5.15) 1967.04 V Gish
Nguyen
Dec 2010
Expert Insight Into: Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor-alpha Blocker in the Treatment of Rheumatic Diseases (Part 11 of Series)Article Review (HBV5.16) 1969.11 V Pan Nov 2010
Expert Insight Into: Long-Term Efficacy of a Nucleotide Analog for Hepatitis B Virus-Monoinfected Patients After Failure of Other Nucleos(t)ide Analogs (Part 10 of Series)Article Review (HBV5.14) 1969.10 V Nguyen Nov 2010
Profiles in Hepatitis B: Customized, Interactive Case ScenariosWebcast w/ Branched Learning (HBV5.12) 1968 V Gish
Kim
Tran
Sep 2010
Expert Insight Into: Nucleoside Analog Treatment for Up to 5 Years in Patients with Hepatitis B e Antigen-positive Chronic Hepatitis B (Part 9 of Series)Article Review (HBV5.13) 1969.09 V Gish Sep 2010
Expert Insight Into: Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with a Nucleoside Analog in Patients with Impaired Liver Function (Part 8 of Series)Article Review (HBV5.11) 1969.08 V Tran Aug 2010
Case Study: Focus on ReactivationTx Reporter e-Newsletter (HBV5.10) 1967.03 V Di Bisceglie Jul 2010
Expert Insight Into: Efficacy of Antiviral Therapy in Chronic Hepatitis B Patients with Mildly Elevated ALT and Histological Liver Damage (Part 7 of Series)Article Review (HBV5.09) 1969.07 V Di Bisceglie Jul 2010
Expert Insight Into: Perinatal Transmission of Hepatitis B Virus: An Australian Experience (Part 6 of Series)Article Review (HBV5.08) 1969.06 V Pan Jun 2010
Expert Insight Into: Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus (Part 5 of Series)Article Review (HBV5.07) 1969.05 V Nguyen May 2010
Case Study: Focus on Basic Disease Management (the "Grey Zone" Patient)Tx Reporter e-Newsletter (HBV5.06) 1967.02 V Gish
Tran
May 2010
Expert Insight Into: Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-Up Study (Part 4 of Series)Article Review (HBV5.05) 1969.04 V Di Bisceglie Apr 2010
Expert Insight Into: Prevalence of Hepatitis B Surface Antigen Among Refugees Entering the United States Between 2006 and 2008 (Part 3 of Series)Article Review (HBV5.04) 1969.03 V Tran Apr 2010
Expert Insight Into: Hepatitis B Testing and Vaccination Among Vietnamese- and Cambodian-Americans (Part 2 of Series)Article Review (HBV5.03) 1969.02 V Gish Mar 2010
Case Study: Focus on Screening and TestingTx Reporter e-Newsletter (HBV5.02) 1967.01 V Di Bisceglie
Pan
Mar 2010
Expert Insight Into: Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C (Part 1 of Series)Article Review (HBV5.01) 1969.01 V Kim Feb 2010